Nisa Investment Advisors’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$485 Buy
584
+287
+97% +$263 ﹤0.01% 2951
2026
Q1
$365 Buy
+297
New +$516 ﹤0.01% 2901
2025
Q4
– Sell
-5,072
Closed -$20.6K – 2996
2025
Q3
$20.6K Buy
5,072
+1,000
+25% +$3.99K ﹤0.01% 1978
2025
Q2
$15.9K Sell
4,072
-2,528
-38% -$7.96K ﹤0.01% 2051
2025
Q1
$19.1K Sell
6,600
-380
-5% -$1.54K ﹤0.01% 1901
2024
Q4
$28.7K Buy
6,980
+6,794
+3,653% +$29.7K ﹤0.01% 1825
2024
Q3
$831 Buy
186
+130
+232% +$610 ﹤0.01% 2620
2024
Q2
$306 Sell
56
-13
-19% -$82 ﹤0.01% 2768
2024
Q1
$557 Buy
69
+14
+25% +$124 ﹤0.01% 2483
2023
Q4
$547 Sell
55
-5
-8% -$39 ﹤0.01% 2386
2023
Q3
$479 Buy
60
+19
+46% +$191 ﹤0.01% 2536
2023
Q2
$451 Sell
41
-359
-90% -$3.7K ﹤0.01% 2579
2023
Q1
$4K Buy
+400
New +$4.71K ﹤0.01% 2257

Other funds holding DH

Nisa Investment Advisors's DH Position: Q2 2026 in Review

Nisa Investment Advisors increased its Definitive Healthcare (DH) stake by 97% in Q2 2026, buying an estimated $263 and bringing the position to 584 shares worth $485. The position accounts for ﹤0.01% of the portfolio, ranked #2951.

Nisa Investment Advisors first reported a position in DH in Q1 2023 and has held it in 13 quarters since. The position peaked at $28.7K in Q4 2024. 99 funds tracked by Wall St. Rank hold DH as of Q2 2026.

  • Nisa Investment Advisors held 584 shares of Definitive Healthcare worth $485 as of Q2 2026.
  • Nisa Investment Advisors bought 287 Definitive Healthcare shares in Q2 2026, an estimated $263.
  • Definitive Healthcare made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2951 holding.
  • Nisa Investment Advisors first reported a position in Definitive Healthcare in Q1 2023 and has held it in 13 quarters since.
  • Nisa Investment Advisors's Definitive Healthcare position peaked at $28.7K in Q4 2024.
  • 99 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.